Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma

被引:35
作者
Elsheikh, Mohamed N.
Rinaldo, Alessandra
Hamakawa, Hiroyuki
Mahfouz, Magdy E.
Rodrigo, Juan Pablo
Brennan, Joseph
Devaney, Kenneth O.
Grandis, Jennifer R.
Ferlito, Alfio
机构
[1] Univ Udine, Dept Surg Sci, ENT Clin, Policlin Univ, I-33100 Udine, Italy
[2] Tanta Univ, Dept Otolaryngol Head & Neck Surg, Tanta, Egypt
[3] Ehime Univ, Dept Oral & Maxillofacial Surg, Matsuyama, Ehime, Japan
[4] Tanta Univ, Dept Biol Sci, Tanta, Egypt
[5] Hosp Univ Cent Asturias, Dept Otolaryngol, Oviedo, Spain
[6] Inst Univ Oncol Principado Asturias, Oviedo, Spain
[7] Wilford Hall USAF Med Ctr, Dept Otolaryngol Head & Neck Surg, Lackland AFB, TX 78236 USA
[8] Foote Hosp, Dept Pathol, Jackson, MI USA
[9] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA
[10] Univ Pittsburgh, Inst Canc, Inst Eye & Ear, Pittsburgh, PA 15260 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2006年 / 28卷 / 09期
关键词
molecular analysis; RT-PCR; cytokeratin; micrometastasis; lymph node metastasis; neck dissection; squamous cell carcinoma; invasion;
D O I
10.1002/hed.20368
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Because of the impact of nodal status on treatment and survival in squamous cell carcinoma of the head and neck, accurate staging of cervical lymph nodes is critical. This article explores the value of molecular analyses in the detection of cervical lymph node metastasis. Methods. A review of the literature was carried out and combined with our own experience regarding the role of molecular analyses in detecting cervical lymph node metastasis. Results. Few studies have demonstrated the diagnostic and prognostic relevance of molecular analysis in detecting tumor cells in lymph nodes. Nodal staging was improved by the use of molecular techniques; when compared with histopathologic examination, however, the small sample size of these studies did not allow definitive conclusions. Conclusions. Molecular analysis is exquisitely sensitive in detecting very small cancer deposits within lymph nodes. It provides an oncologic basis that may be used to guide therapy and influence outcomes. It should be recommended for diagnostic use in controlled studies of patients without evidence of lymph node metastasis on routine hematoxylin-eosin-stained sections. The clinical significance of these types of metastases, however, must be determined with carefully designed and controlled prospective clinical trials. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:842 / 849
页数:8
相关论文
共 47 条
[21]   Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients [J].
Kawamata, H ;
Uchida, D ;
Nakashiro, K ;
Hino, S ;
Omotehara, F ;
Yoshida, H ;
Sato, R .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :448-452
[22]  
Makino H, 2003, HEPATO-GASTROENTEROL, V50, P1407
[23]   THE CATALOG OF HUMAN CYTOKERATINS - PATTERNS OF EXPRESSION IN NORMAL EPITHELIA, TUMORS AND CULTURED-CELLS [J].
MOLL, R ;
FRANKE, WW ;
SCHILLER, DL ;
GEIGER, B ;
KREPLER, R .
CELL, 1982, 31 (01) :11-24
[24]   THE HUMAN GENE ENCODING CYTOKERATIN-20 AND ITS EXPRESSION DURING FETAL DEVELOPMENT AND IN GASTROINTESTINAL CARCINOMAS [J].
MOLL, R ;
ZIMBELMANN, R ;
GOLDSCHMIDT, MD ;
KEITH, M ;
LAUFER, J ;
KASPER, M ;
KOCH, PJ ;
FRANKE, WW .
DIFFERENTIATION, 1993, 53 (02) :75-93
[25]  
Nagler RM, 2002, ANTICANCER RES, V22, P2977
[26]   Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction [J].
Nieuwenhuis, EJC ;
Leemans, CR ;
Kummer, A ;
Denkers, F ;
Snow, GB ;
Brakenhoff, RH .
LABORATORY INVESTIGATION, 2003, 83 (08) :1233-1240
[27]  
Nieuwenhuis EJC, 2003, CLIN CANCER RES, V9, P755
[28]  
Okami J, 2000, CLIN CANCER RES, V6, P2326
[29]  
Onishi A, 2004, ONCOL REP, V11, P33
[30]   Detection and clinical importance of micrometastatic disease [J].
Pantel, K ;
Cote, RJ ;
Fodstad, O .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (13) :1113-1124